Archive for November, 2008

The History Behind Cialis and its Manufacturers

Tuesday, November 25th, 2008

Eli Lilly is the manufacturer of Cialis (Tadalafil). Cialis has a big advantage over its two other competitors and it is a big one. The others last only about four hours after ingested but Cialis can brag about a whopping…

Why To Go For Canadadrugpharmacy.com

Saturday, November 22nd, 2008

Buying drug to get rid of a disease is not a tedious task. But when it comes to receiving quality drug at an affordable price, the story seems to be different. With the introduction of World Wide Web, innumerable…

Nurse Practitioner - New indication for alendronate

Thursday, November 20th, 2008

DUBLIN, Ireland — Research and Markets (http://www.researchandmarkets.com/reports/c62454) has announced the addition of Commercial Insight: Osteoporosis - Risk Management and Reformulation Offer Best Defense against Gene…

Science News - Two drugs are equal in preventing breast cancer. with tamoxifen

Tuesday, November 18th, 2008

As many as 9 million postmenopausal U.S. women might be at an increased risk of breast cancer, scientists say. Yet few have opted to take tamoxifen, the only drug now approved for breast cancer risk reduction, because it raises the risk of uterine cancer and potentially deadly blood clots.
Researchers reported Monday that the osteoporosis drug raloxifene, marketed as Evista, is safer than tamoxifen and just as effective in reducing th…

CanadianPharmacymeds: A Complete Online Drug Store

Wednesday, November 12th, 2008

All the medications shipped by CanadianPharmacyMeds are approved by licensed pharmacist and then delivered to the respective customers. The accredited Canadian pharmacy only dispatches medications approved by Health Canada, the federal regulatory body of …

Market Wire - Shasta Pools & Spas Deploys Document Imaging Solution From eCopy and OptiScan

Sunday, November 9th, 2008

Shasta Pools & Spas has deployed eCopy(TM)
ShareScan document imaging software along with OptiScan eVista(TM)
document management software to support its production and financial
processes for building …

Australian Doctor - Evista findings positive but not clear-cut.

Wednesday, November 5th, 2008

By Cathy Saunders

FINDINGS that osteoporosis drug raloxifene (Evista) can halve the risk of invasive breast cancer with fewer side effects than tamoxifen have been welcomed by an Australian expert.

However, it was premature to consider the drug for breast cancer prevention among the study’s …